- NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News
- Resurgence in HiSeq Sales Helps Drive Illumina Revenue Growth in Q1 2013
April 23, 2013 / In Sequence
- Comparison Suggests 454, Illumina, and SOLiD Sequences Each Harbor SNVs Missed by Other Two Platforms
February 12, 2013 / In Sequence
- MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing
January 29, 2013 / In Sequence
- Analysts Increase Valuations, Upgrade Illumina
January 4, 2013 / GenomeWeb Daily News